NCT04210622View on ClinicalTrials.gov

An Initial Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System

CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

July 4, 2019

Study Completion Date

June 18, 2020

Conditions
Atrial FibrillationAtrial Flutter
Interventions
DEVICE

Catheter mapping and ablation with the Sphere-9 Catheter and Affera Mapping and Ablation System

Catheter mapping and ablation with the Sphere-9 Catheter and Affera Mapping and Ablation System

Trial Locations (1)

Unknown

Vilnius University Hospital, Vilnius

All Listed Sponsors
lead

Medtronic Cardiac Ablation Solutions

INDUSTRY

NCT04210622 - An Initial Assessment of the Sphere-9™ Catheter and Affera Mapping and Ablation System | Biotech Hunter | Biotech Hunter